HEALTH● LOWAug 14 · Aug 14, 2026, 7:29 AM
U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma
The Hindu
A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH13m agoKenya records second Ebola case as outbreak in Congo keeps growingEuroNews [en]HEALTH23m agoI work in the NHS and Malawi – we need to urgently rethink how we see health spendingThe Independent WorldHEALTH1h agoVaccines, antibiotics: Africa's push for pharma independence [Business Africa]Africanews [en]HEALTH1h agoNumber of people receiving weight loss jabs on NHS in Scotland revealedthenational.scot · United Kingdom